Biologics Market Research Reports & Industry Analysis
The biologics industry includes a wide range of therapeutic products derived from biological sources and is a fundamental part of modern healthcare. Biologics play a vital role in advancing treatments for various diseases and conditions. MarketResearch.com offers a comprehensive collection of biologics industry reports to provide valuable insights into the most recent market trends, challenges, and opportunities to watch.
Biologics Market Growth Forecasts
- Access detailed information about a variety of distinct market segments, such as recombinant proteins, vaccines, and more.
- Obtain biologics market sizing and growth projections to gain a clear understanding of market potential and outlook.
- Analyze leading players and competitor strategies to stay one step ahead in a competitive market.
The MarketResearch.com Advantage
MakretResearch.com has been a trailblazer in the field of market research for more than two decades and continues to serve many of the largest life science and biotech companies in the world. With MarketResearch.com’s reliable data-driven insights, you can make informed decisions to guide your business towards success. Choose MarketResearch.com and gain the edge today.
Biologics Industry Research & Market Reports
-
Biologics Contract Development Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented By Source (Mammalian, Microbial, Others), By Service (Cell Line Development, Process Development, Others), By Indication (Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Others) Region and Competition
... Hematological Disorders, Others) Region and Competition Global Biologics Contract Development Market was valued at USD 7.12 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 7.22% ... Read More
-
Biologics CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... billion by 2029, growing at a CAGR of 12.78% during the forecast period (2024-2029). With an increasing number of companies within the pharmaceutical sector considering outsourcing services, the demand for services from contract manufacturing and ... Read More
-
Global Contract Development and Manufacturing Organization (CDMO) Market: Analysis By Type (Chemical Drugs & Biologics), By Product (API/Bulk Drugs Drug Product Manufacturing (Inc. Dosage & Formulation Development) & Packaging), By Sourcing (In House & Outsourced), By Application (Oncology, Cardiovascular Disease, Diabetes, Hormonal, Glaucoma & Others), By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029
... By Application (Oncology, Cardiovascular Disease, Diabetes, Hormonal, Glaucoma & Others), By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029 The global contract development and manufacturing organization (CDMO) market was valued ... Read More
-
2024 Global Other Biologics, Excluding Diagnostic, For Human Use Products Markets (2030 Outlook)
... for 46 countries (Wharry Sharpe Research) The Global Products Markets Outlook reports provide product market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) ... Read More
-
Hernia Repair Market by Product (Mesh (Synthetic, Biologic), Suture (Absorbable, Non-Absorbable), Tack, Glue Applicator), Indication (Inguinal, Incisional, Umbilical, Epigastric, Femoral, Hiatal), Surgery, End-user - Global Forecast to 2029
... to reach USD 5.1 billion by 2029 from USD 4.1 billion in 2024, growing at a CAGR of 4.2% during the forecast period. The increasing number of hernia repair procedures is one of the major ... Read More
-
Lyophilization Services For Biopharmaceuticals Global Market Report 2024
... Application: Pharmaceutical And Biotechnology Companies; Research InstitutesCovering: Strides Pharma Science Limited; Baxter International Inc.; Catalent Pharma Solutions Inc; W. L. Gore & Associates Inc; Emergent BioSolutions Inc. Lyophilization Services For Biopharmaceuticals Global Market Report 2024 ... Read More
-
Biologics Outsourcing Global Market Report 2024
... Research4) By End User: Pharmaceutical Industries; Biotechnology Industries; Contract Development And Manufacturing Organization(CDMO)Covering: AbbVie Inc.; Thermo Fisher Scientific Inc.; Boehringer Ingelheim GmbH; Lonza Group Ag; Catalent Inc. Biologics Outsourcing Global Market Report 2024 from The ... Read More
-
Veterinary Biologics Global Market Report 2024
... By Application: Production Animal; Companion AnimalCovering: Bayer AG; Eli Lilly & Company;Evonik Industries AG; Zoetis Inc.; VCA Inc. Veterinary Biologics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management ... Read More
-
Retinal Biologics Global Market Report 2024
... Hospitals; Pharmacies; Specialty Clinics; Online PharmaciesCovering: Pfizer Inc.; F. Hoffmann-La Roche Ltd; Merck & Co Inc; AbbVie Inc.; Bayer AG Retinal Biologics Global Market Report 2024 from The Business Research Company provides strategists, marketers and ... Read More
-
Biopharmaceutical Third-Party Logistics Global Market Report 2024
... Corporation; AmerisourceBergen Corporation; United Parcel Service of America Inc.; FedEx Corporation; DHL International GmbH Biopharmaceutical Third-Party Logistics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical ... Read More
-
India Life Science Tools Market Assessment, By Type [Instruments, Consumables, Services], By Technology [Genomics, Proteomics, Cell Biology Technology, Lab Supplies, Others], By Product [Cell Culture Systems & 3D Cell Culture, Liquid Chromatography, Mass Spectrometry, Flow Cytometry, Cloning & Genome Engineering, Microscopy, Next Generation Sequencing, PCR & qPCR, Nucleic Acid Preparation, Nucleic Acid Microarray, Sanger Sequencing, Transfection Device & Gene Delivery Technologies, Nuclear Magnetic Resonance, Others], By End-user [Healthcare, Government & Academic Institutions, Biopharmaceutical Company, Industrial Applications, Others], By Region, Opportunities and Forecast, FY2017-FY2031F
... Cytometry, Cloning & Genome Engineering, Microscopy, Next Generation Sequencing, PCR & qPCR, Nucleic Acid Preparation, Nucleic Acid Microarray, Sanger Sequencing, Transfection Device & Gene Delivery Technologies, Nuclear Magnetic Resonance, Others], By End-user [Healthcare, Government & ... Read More
-
Microcarriers Market - By Products (Consumables {Media, Microcarrier Beads}, Equipment {Bioreactor, Cell Counter}), Application (Biopharmaceutical Production, Regenerative Medicine), End-user (CROs, Research Institutes), Global Forecast, 2024 - 2032
... CAGR during 2024-2032, driven by Increasing adoption of microcarriers in cell culture processes, advancements in R&D activities, expanding applications beyond traditional cell culture processes, and rising demand for cell-based therapies and biologics. Urbanization leads to ... Read More
-
Regenerative Medicine Market Assessment, By Component [Therapeutics, Tools, Banks, Services], By Product [Gene Therapy, Cell Therapy, Tissue Engineering, Organ Therapy, Small Molecules and Biologics], By Material [Synthetic Material, Biologically Derived Material, Genetically Engineered Material, Others], By Application [Wound Care, Musculoskeletal, Ophthalmology, Oncology, Cardiovascular, Dermatology, Neurology, Others], By End-user [Hospitals, Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F
... By Application [Wound Care, Musculoskeletal, Ophthalmology, Oncology, Cardiovascular, Dermatology, Neurology, Others], By End-user [Hospitals, Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F Global regenerative medicine market size was valued at USD 24.91 billion in 2023, ... Read More
-
Recombinant Proteins Market Assessment, By Product [Cytokines and Growth Factors, Antibodies, Immune Checkpoint Proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones, Others], By Host Cell [Mammalian Systems, Insect Cells, Yeast and Fungi, Bacterial Cells, Others], By Application [Academic Research Studies, Biopharmaceutical Production, Biotechnology Research, Diagnostics, Other Applications], By End-user [Pharmaceutical and Biotechnology Companies, Academics and Research Institutions, Clinical Research Organization, Diagnostic Laboratories, Others], By Region, Opportunities and Forecast, 2017-2031F
... By Application [Academic Research Studies, Biopharmaceutical Production, Biotechnology Research, Diagnostics, Other Applications], By End-user [Pharmaceutical and Biotechnology Companies, Academics and Research Institutions, Clinical Research Organization, Diagnostic Laboratories, Others], By Region, Opportunities and Forecast, 2017-2031F Global ... Read More
-
Biologics Market Assessment, By Product [Monoclonal Antibodies, Recombinant Hormones/Proteins, Vaccines, Cellular Based Biologics, Gene-Based Biologics, Therapeutic Enzymes, Others] By Application [Infectious Diseases, Cancer, Autoimmune Diseases, Cardiovascular, Hematological Disorders, Others] By Drug Classification [Branded Drugs, Generic Drugs], By Mode of Purchase [Prescription Drugs, Over-the-counter Drugs] By Distribution Channel [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies] By Region, Opportunities and Forecast, 2017-2031F
... Drugs], By Mode of Purchase [Prescription Drugs, Over-the-counter Drugs] By Distribution Channel [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies] By Region, Opportunities and Forecast, 2017-2031F Global biologics market size was valued at USD 401.34 billion in ... Read More
-
Cancer biologics Global Market Report 2024
... Cancer; Colorectal Cancer; Gastric Cancers3) By Distribution Channel: Hospitals; ClinicsCovering: AbbVie Inc.; F. Hoffmann-La Roche AG; GlaxoSmithKline plc; Eli Lilly and Company; AmgenInc. Cancer biologics Global Market Report 2024 from The Business Research Company provides ... Read More
-
Oral Biologics & Biosimilar Drugs Global Market Report 2024
... Psoriasis3) By Molecule Type: Vaccines; Proteins & Peptides; Monoclonal Antibodies4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Novartis International AG; Rani Therapeutics Holdings Inc.; Eli Lilly and Company; AstraZeneca plc; Novo Nordisk A/S ... Read More
-
Global Cancer Biologics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
South & Central America Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis - By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-ischemic Ulcers), Treatment Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Mild, Moderate, and Severe), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care)
... Infection Severity (Mild, Moderate, and Severe), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care) The South & Central America diabetic foot ulcer market was valued at US$ 356.91 million in 2022 and is ... Read More
-
Asia Pacific Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis -By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-ischemic Ulcers), Treatment Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Moderate, Mild, and Severe), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care)
... Mild, and Severe), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care) The Asia Pacific diabetic foot ulcer market was valued at US$ 1,455.82 million in 2022 and is expected to reach US$ 2,472.61 ... Read More
-
Middle East & Africa Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis - By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-ischemic Ulcers), Treatment Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Mild, Moderate, and Severe), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care)
... Infection Severity (Mild, Moderate, and Severe), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care) The Middle East & Africa diabetic foot ulcer market was valued at US$ 249.80 million in 2022 and is ... Read More
-
Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Research, Biopharma Production) & Region - Global Forecast to 2028
... recombinant proteins market size is projected to reach USD 3.2 billion by 2028 from USD 2.2 billion in 2023, at a CAGR of 7.2% during the forecast period. Factors such as rising demand for biologics ... Read More
-
Europe Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis -By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-ischemic Ulcers), Treatment Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Moderate, Mild, and Severe), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care)
... and Severe), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care) The Europe diabetic foot ulcer market was valued at US$ 1,837.31 million in 2022 and is expected to reach US$ 2,924.75 million by ... Read More
-
North America Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis -By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-ischemic Ulcers), Treatment Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Moderate, Mild, and Severe), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care)
... Mild, and Severe), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care) The North America diabetic foot ulcer market was valued at US$ 3,570.76 million in 2022 and is expected to reach US$ 5,943.56 ... Read More
-
Erythropoietin Drugs Market Forecasts to 2030 – Global Analysis By Type (Biosimilars and Biologics), Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa and Other Products), Distribution Channel, Application, End User and By Geography
... Erythropoietin Drugs Market is accounted for $10.7 billion in 2023 and is expected to reach $25.6 billion by 2030 growing at a CAGR of 13.2% during the forecast period. Erythropoietin drugs are a class of ... Read More
Research Assistance
